Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A SINGLE-ARM, OPEN LABEL, MULTI-CENTER EARLY FEASIBILITY STUDY OF THE LUSEED ANEURYSM EMBOLIZATION SYSTEM IN INDIVIDUALS WITH UPRUPTURED INTRACRANIAL ANEURYSMS

NCT06761365 is registered in ClinicalTrials.gov with LuSeed Vascular LTD. as lead sponsor.

NCT NCT06761365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06761365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A SINGLE-ARM, OPEN LABEL, MULTI-CENTER EARLY FEASIBILITY STUDY OF THE LUSEED ANEURYSM EMBOLIZATION SYSTEM IN INDIVIDUALS WITH UPRUPTURED INTRACRANIAL ANEURYSMS
Lead sponsor
LuSeed Vascular LTD.
Phase
Not applicable
Overall status
Recruiting
Start date
October 7, 2024
Completion date
June 30, 2027
Enrollment
30 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysm cerebral, bifurcation, brain aneurysm, saccular aneurysm, unruptured intracranial aneurysm